OFI Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$122K Sell
1,315
-844
-39% -$74.4K 0.01% 1413
2015
Q2
$142K Buy
2,159
+48
+2% +$3.19K 0.01% 1388
2015
Q1
$151K Sell
2,111
-174
-8% -$9.45K 0.01% 1364
2014
Q4
$87K Sell
2,285
-796
-26% -$25.1K 0.01% 1518
2014
Q3
$77K Sell
3,081
-162
-5% -$4.1K 0.01% 1533
2014
Q2
$82K Buy
3,243
+536
+20% +$12.5K 0.01% 1522
2014
Q1
$70K Buy
2,707
+386
+17% +$10.7K 0.01% 1531
2013
Q4
$62K Buy
2,321
+92
+4% +$2.27K 0.01% 1553
2013
Q3
$42K Buy
2,229
+611
+38% +$14K ﹤0.01% 1590
2013
Q2
$35K Buy
+1,618
New +$32.5K ﹤0.01% 1579

Other funds holding ABMD

OFI Advisors's ABMD Position: Q3 2015 in Review

OFI Advisors reduced its Abiomed Inc (ABMD) stake by 39% in Q3 2015, selling an estimated $74.4K and leaving 1,315 shares worth $122K. The position accounts for 0.01% of the portfolio, ranked #1413.

OFI Advisors first reported a position in ABMD in Q2 2013 and has held it in 10 quarters since. The position peaked at $151K in Q1 2015. 243 funds tracked by Wall St. Rank hold ABMD as of Q3 2015.

  • OFI Advisors held 1,315 shares of Abiomed Inc worth $122K as of Q3 2015.
  • OFI Advisors sold 844 Abiomed Inc shares in Q3 2015, an estimated $74.4K.
  • Abiomed Inc made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1413 holding.
  • OFI Advisors first reported a position in Abiomed Inc in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Abiomed Inc position peaked at $151K in Q1 2015.
  • 243 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.